Gemigliptin, Metformin Combo Beats Monotherapy in T2DM

This article originally appeared here.
Share this content:
Gemigliptin, Metformin Combo Beats Monotherapy in T2DM
Gemigliptin, Metformin Combo Beats Monotherapy in T2DM

TUESDAY, Sept. 20, 2016 (HealthDay News) -- Gemigliptin combined with metformin is superior to monotherapy with either drug for patients with type 2 diabetes mellitus (T2DM), according to a study published online Sept. 13 in Diabetes, Obesity and Metabolism.

Soo Lim, M.D., Ph.D., from the Seoul National University College of Medicine in South Korea, and colleagues randomized 433 patients with T2DM with a glycosylated hemoglobin (HbA1c) level of 7.5 to 11.0 percent and fasting plasma glucose concentration <270 mg/dL to receive either gemigliptin plus metformin, gemigliptin alone, or metformin alone. The change in HbA1c at 24 weeks was assessed as the primary end point.

The researchers found that from baseline to week 24 the mean changes in HbA1c were −2.06 percent, −1.24 percent, and −1.47 percent, respectively, in the combination, gemigliptin monotherapy, and metformin monotherapy groups, respectively. For between-group differences in HbA1c changes, the 95 percent confidence intervals were −1.02 to −0.63 for the combination group versus the gemigliptin group, and −0.82 to −0.41 for the combination group versus the metformin group. Compared with the monotherapy groups, the percentage of patients in the combination therapy group that reached the target HbA1c level <7 percent (or <6.5 percent) was significantly higher. There were no reports of serious side effects.

"In T2DM patients, the initial combination of gemigliptin and metformin had superior efficacy without safety concerns compared with monotherapy with either drug," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

Caffeine Found to Reduce Age-Related Inflammation

Caffeine Found to Reduce Age-Related Inflammation

Connection between advancing age, systemic inflammation, cardiovascular disease and caffeine

Neonatal Abstinence Syndrome Tied to Poor School Performance

Neonatal Abstinence Syndrome Tied to Poor School Performance

By seventh grade, four out of 10 failed to meet standards in at least one academic area

Heart Rate Variability Linked to Atrial Fibrillation

Heart Rate Variability Linked to Atrial Fibrillation

Lower HRV, increased sympathetic/parasympathetic tone linked to higher risk of a-fib

is free, fast, and customized just for you!

Already a member?

Sign In Now »